Eagan, MN, October 7, 2020–Recombinetics Inc., a leading gene editing company with platform technology in therapeutics development, today announced that it has merged its efforts with Makana Therapeutics, a leader in the field of xenotransplantation. Makana Therapeutics will become Recombinetics Inc.’s newest subsidiary and will be exclusively focused on solving [...]